December 15th, 2015

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

271.67 USD -3.87 (-1.40%)
Official Closing Price Updated: 7:09 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
Biogen Moves $10 Million To Black-Owned OneUnited, Joining the Fortune 500 Trend To 'Bank Black'
Tags NASDAQ:BIIB Bank Black Economic Empowerment
From 3BL Media: Corporate Social Responsibility, Energy and Health News
New Biogen Data Presented at ACTRIMS-ECTRIMS Advance Understanding of Clinical and Health Disparities in MS
From GlobeNewswire News Releases
OneUnited Bank, Fintech Pioneer, Announces $10 Million Deposit By Biogen To Support #BankBlack Movement
Bank chosen for cutting-edge technology and leading the way to close racial wealth gap 
From PR Newswire
Novel Cancer Treatments Arise as Scientists Search for Answers
FinancialBuzz.com News Commentary 
From PR Newswire
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
From GlobeNewswire News Releases
Thinking about trading options or stock in Biogen Inc, Nio Inc, Zillow Group, Square Inc, or Apple?
InvestorsObserver issues critical PriceWatch Alerts for BIIB, NIO, ZG, SQ, and AAPL. 
From PR Newswire
FDA Accepts Biogen’s Aducanumab Biologics License Application for Alzheimer's Disease with Priority Review
From GlobeNewswire News Releases
Biogen and Denali to Collaborate on LRRK2 Program for Parkinson’s Disease and Certain TV Platform-Enabled Programs for Neurodegenerative Diseases
From GlobeNewswire News Releases
Inspiring the Next Generation of Scientists in a New Way
Tags NASDAQ:BIIB Access to Technology Biogen
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Doctors Reap the Benefits of Improving Diagnostic Capabilities
FinancialBuzz.com News Commentary 
From PR Newswire
Biogen to Present Data at Virtual 2020 Alzheimer’s Association International Conference Highlighting Comprehensive Approach to Alzheimer’s Disease
From GlobeNewswire News Releases
Biogen Names Michael McDonnell as Executive Vice President and Chief Financial Officer
From GlobeNewswire News Releases
JoVE and Biogen to Provide Somerville Public Schools with STEM Video Learning Resources
Tags Corporate Contributions Partnerships STEM
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Biogen Plans to Initiate Phase 4 Study Evaluating Benefit of SPINRAZA® (nusinersen) in Patients Treated with Zolgensma® (onasemnogene abeparvovec)
From GlobeNewswire News Releases
Initiation Of New Phase III Clinical Study (AHEAD 3-45) Of BAN2401 Preclinical (Asymptomatic) Alzheimer's Disease
The Alzheimer's Clinical Trials Consortium (ACTC), Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), and Biogen Inc. (Nasdaq: BIIB, Headquarters: Cambridge, Massachusetts, United... 
From PR Newswire
Fulfilling Our Commitment to Sustainability
Tags CSR Reports Research, Reports & Publications Environment
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Biogen Completes Submission of Biologics License Application to FDA for Aducanumab as a Treatment for Alzheimer's Disease
From ACN Newswire
Advocacy Through Action: Protecting Massachusetts Nursing Home Residents and Staff from COVID-19
Tags Massachusetts Senior Care Association coronavirus Public Health
From 3BL Media: Corporate Social Responsibility, Energy and Health News
The New England Journal of Medicine Publishes Final Results from Phase 1/2 Study of Tofersen for a Genetic Form of ALS
From GlobeNewswire News Releases
Thinking about trading options or stock in Biogen Inc, Alcoa Corp, Square Inc, Norwegian Cruise Line, or Boeing?
InvestorsObserver issues critical PriceWatch Alerts for BIIB, AA, SQ, NCLH, and BA. 
From PR Newswire
Biogen Completes Submission of Biologics License Application to FDA for Aducanumab as a Treatment for Alzheimer’s Disease
From GlobeNewswire News Releases
Increasing Diversity in Clinical Trials: A Collaboration with Tufts Center for the Study of Drug Development
Tags Research & Policy Improving Healthcare Access Pharma News, Research & Solutions
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Addressing Needs of Low-Income Populations
Tags Philanthropy & Cause Initiatives Biogen Foundation COVID/19
From 3BL Media: Corporate Social Responsibility, Energy and Health News
MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings
From GlobeNewswire News Releases
The Hidden Face of MS
Tags Reduced Inequalities Health & Healthcare MS
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Honoring Our Intersectional Pride
Tags Employee Engagement LGBTQ NASDAQ:BIIB
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Biogen Ranked #1 Biotech on Climate - 100 Best Corporate Citizens
Tags Sustainability NASDAQ:BIIB Biogen
From 3BL Media: Corporate Social Responsibility, Energy and Health News
New Results From Landmark NURTURE Study Show That Pre-Symptomatic SMA Patients Treated With SPINRAZA® (nusinersen) Continue to Demonstrate Sustained Benefit From Treatment
From GlobeNewswire News Releases
Biogen Presents Positive Phase 2 Cutaneous Lupus Erythematosus (CLE) Data at European E-Congress of Rheumatology (EULAR) 2020
From GlobeNewswire News Releases
Vir Biotechnology and Biogen Execute Agreement to Manufacture SARS-CoV-2 Antibodies for Potential COVID-19 Treatment
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
57 58 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

More ways to get to us

Medicine Hat News Twitter Twitter
Medicine Hat News Facebook Facebook
Medicine Hat News YouTube YouTube
Medicine Hat News Tumblr Tumblr

About Us

Contact the Medicine Hat News

3257 Dunmore Rd SE
Medicine Hat, AB T1B 3R2

[P] 403.527.1101
[F] 403.528.5696

Print Advertising: 403.528.5650
National Advertising: 403.528.5766
Online Advertising: 403.528.5698
Classifieds: 403.526.7653

© 1996-2015 The Medicine Hat News, A Division of Continental Newspapers Canada Ltd.